Douglass H. Laidlaw
Geen lopende functies
Profiel
Douglass H.
Laidlaw worked as a Director-Medical Affairs at Keryx Biopharmaceuticals, Inc. and as a Senior Director-Medical Affairs at Talaris Therapeutics, Inc. He also worked as a Vice President-Medical Affairs at OPKO Health, Inc. from 2016 to 2017.
Laidlaw completed his undergraduate degree at Sonoma State University and his graduate and doctorate degrees at the University of Arizona.
Eerdere bekende functies van Douglass H. Laidlaw
| Bedrijven | Functie | Einde |
|---|---|---|
| TOURMALINE BIO, INC. | Chief Tech/Sci/R&D Officer | 01-02-2023 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01-06-2017 |
| KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
Opleiding van Douglass H. Laidlaw
| Sonoma State University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OPKO HEALTH, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
